Vertero is innovating beyond the brain to develop differentiated therapies to turn the tide of challenging neurodegenerative diseases and preserve patients’ quality of life for longer
Vertero is innovating beyond the brain to develop differentiated therapies to turn the tide of challenging neurodegenerative diseases and preserve patients’ quality of life for longer. The company targets causative mechanisms that lie outside the brain, in the peripheral nervous system, with a focus on developing oral therapeutics for neurodegenerative diseases like Parkinson's disease.